Inclusion of Cephalexin in COVID-19 Treatment Combinations May Prevent Lung Involvement in Mild Infections: A Case Report with Pharmacological Genomics Perspective

by Amir Khodavirdipour
Published 2021-03-01

Impact of SARS-CoV-2 Genetic Blueprints on the Oral Manifestation of COVID-19: A Case Report

by Amir Khodavirdipour, Mahsa Asadimanesh, Seyed Alireza Masoumi
Published 2021-09-01

Concise Update on Genomics of COVID-19: Approach to Its latest Mutations, Escalated Contagiousness, and Vaccine Resistance

by Amir Khodavirdipour, Sarvin Jabbari, Fariba Keramat, Mohammad Y. Alikhani
Published 2021-03-01

Potential of CRISPR/Cas13 System in Treatment and Diagnosis of COVID-19

by Amir Khodavirdipour, Motahareh Piri, Sarvin Jabbari, Mohammad Khalaj-kondori
Published 2021-02-01

SARS-CoV-2; from vaccine development to drug discovery and prevention guidelines

by Amir Khodavirdipour, Fariba Keramat, Seyed Hamid Hashemi, Mohammad Yousef Alikhani
Published 2020-12-01

Molecular typing of multi-drug resistant Acinetobacter baumannii isolates from clinical and environmental specimens in three Iranian hospitals by pulsed field gel electrophoresis

by Ali Mohammadi Bardbari, Parviz Mohajeri, Mohammad Reza Arabestani, Manoochehr Karami, Fariba Keramat, Saba Asadollahi, Amir Khodavirdipour, Mohammad Yousef Alikhani
Published 2020-04-01